COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

about

Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012.

P2860

Q38823135-80623F8B-6C11-4136-AF8C-5F2EB6321FDA

P2860

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

Item

http://www.wikidata.org/entity/Q36853019

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

@en

type

Item

label

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

@en

prefLabel

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

@en

P1476

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

@en

P2093

Alma Mekic-Abazovic

http://www.w3.org/2001/XMLSchema#string

Samra Sulejmanovic

http://www.w3.org/2001/XMLSchema#string

Tarik Catic

http://www.w3.org/2001/XMLSchema#string

P2860

Econometric estimation of country-specific hospital costs

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients.

Economic burden of haematological adverse effects in cancer patients: a systematic review.

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.

Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices.

Impact of chemotherapy dose intensity on cancer patient outcomes.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

P304

112-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5455/MSM.2016.28.112-114

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299434257

http://www.w3.org/2001/XMLSchema#string

P698

27147916

http://www.w3.org/2001/XMLSchema#string

P932

4851529

http://www.w3.org/2001/XMLSchema#string

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

about

P2860

P2860

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932